GI tract, lungs, heart, kidneys, and nervous system
•
GI: 3rd most common manifestation after skin changes and Raynaud phenomenon
Seen in up to 90% of patients
Most common sites
–
Esophagus > duodenum > anorectal > small bowel > colon
•
Interstitial pulmonary fibrosis, often severe
•
Scleroderma is classified into 2 types
Diffuse scleroderma and CREST syndrome
•
Diffuse scleroderma
Cutaneous and visceral involvement
•
CREST syndrome: Minimal cutaneous and late visceral
C: Calcinosis of skin
R: Raynaud phenomenon
E: Esophageal dysmotility
S: Sclerodactyly (involvement of fingers)
T: Telangiectasia
•
Esophagography
Atony or aperistalsis: Lower 2/3 (smooth muscle)
Mild to moderate dilatation of esophagus
Patulous lower esophageal sphincter (early)
Ulcers, fusiform peptic stricture (later)
Gastroesophageal reflux (70% of patients)
40% develop Barrett esophagus
TOP DIFFERENTIAL DIAGNOSES
•
Reflux esophagitis (with stricture)
TERMINOLOGY
Synonyms
•
Progressive systemic sclerosis
Definitions
•
Multisystem disorder of small vessels and connective tissue (collagen vascular disease) of unknown etiology
IMAGING
General Features
•
Best diagnostic clue
Dilated atonic esophagus with distal stricture (late findings)
•
Other general features
Multisystemic disorder with immunologic and inflammatory changes
Characterized by atrophy, fibrosis, and sclerosis of skin, vessels, and organs
Involves skin, synovium, and parenchyma of multiple organs
–
Gastrointestinal tract, lungs, heart, kidneys, and nervous system
Gastrointestinal (GI) tract scleroderma
–
3rd most common manifestation after skin changes and Raynaud phenomenon
–
Seen in up to 90% of patients
–
Most common sites: Esophagus > duodenum > anus/rectum > small bowel > colon
–
Most frequent cause of chronic intestinal pseudo-obstruction
Scleroderma is classified into 2 types
–
CREST syndrome (more benign course)
Diffuse scleroderma: Cutaneous and visceral involvement
–
Interstitial pulmonary fibrosis, often severe
–
Organ failure more likely
–
Associated with antitopoisomerase 1 antibody (anti-Scl 70)
CREST syndrome: Minimal cutaneous and late visceral involvement
–
E: Esophageal dysmotility
–
S: Sclerodactyly (involvement of fingers)
–
Associated with anticentromere antibodies
Radiographic Findings
•
Fluoroscopic-guided esophagography
Normal peristalsis above aortic arch (striated muscle)
Atony or aperistalsis: Lower 2/3 (smooth muscle)
Mild to moderate dilatation of esophagus
Patulous lower esophageal sphincter (LES)
–
Early finding of scleroderma
Erosions, superficial ulcers, fusiform peptic stricture
–
Due to reflux esophagitis
Gastroesophageal reflux (70% cases)
–
40% develop Barrett esophagus
Hiatal hernia